Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure by Emi Watanabe-Fujinuma, Hideki Origasa, Luke Bamber, Lothar Roessig, Tetsumi Toyoda, Yuri Haga, Chad Gwaltney, Burkert Pieske

Get full text

Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial by Michele Senni, Jose Lopez‐Sendon, Alain Cohen‐Solal, Piotr Ponikowski, Richard Nkulikiyinka, Cecilia Freitas, Vanja Miodrag Vlajnic, Lothar Roessig, Burkert Pieske

Get full text

Left atrial strain as sensitive marker of left ventricular diastolic dysfunction in heart failure by Athanasios Frydas, Daniel A. Morris, Evgeny Belyavskiy, Aravind‐Kumar Radhakrishnan, Martin Kropf, Marijana Tadic, Lothar Roessig, Carolyn S.P. Lam, Sanjiv J. Shah, Scott D. Solomon, Burkert Pieske, Elisabeth Pieske‐Kraigher

Get full text

Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY‐HFpEF trial by Javed Butler, Muhammad Shahzeb Khan, Tomasz Gasior, Tyler R. Erickson, Vanja Vlajnic, Frank Kramer, Robert O. Blaustein, David Goldsbury, Lothar Roessig, Carolyn S.P. Lam, Kevin J. Anstrom, Paul W. Armstrong, for the VITALITY Study Group

Get full text

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial by Carolyn S. P. Lam, Hillary Mulder, Yuri Lopatin, Jose B. Vazquez‐Tanus, David Siu, Justin Ezekowitz, Burkert Pieske, Christopher M. O’Connor, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Adrian F. Hernandez, Paul W. Armstrong

Get full text